employed a 4-gene panel (CTNNB1, PTEN, KRAS, and PIK3CA) to analyze paired plasma and tumor tissues from 48 cases of endometrioid carcinoma. This evidence concerns the gene KRAS and endometrioid adenocarcinoma.